Stocks
Arcturus Therapeutics Holdings (ARCT) EV/EBITDA US GAAP (year values) |
||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | |||
| EV/EBITDA | ? | 11.0 | -6.91 | -23.9 | -3.23 | 0.53 | -0.53 | |
| Changes by years, y/y, % | -431% | -163% | +246% | -87% | -116% | |||
Arcturus Therapeutics Holdings. EV/EBITDA
Arcturus Therapeutics Holdings. EV/EBITDA, changes, %
Arcturus Therapeutics Holdings (ARCT) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EV/EBITDA | ? | -2.93 | -1.57 | -2.95 | -4.98 | 0.53 | -0.53 | |
| Changes by years, y/y, % | -65% | -73% | -38% | -21% | -118% | |||
| Changes by quarters, q/q, % | -54% | -46% | +87% | +69% | -111% | |||
